Missouri – Marijuana can be extremely dangerous, even deadly, for small children. Store all …
#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should counsel patients on safe storage of cannabis products, particularly edibles and concentrates that are attractive to young children and pose serious toxicity risks including seizures, respiratory depression, and death. This guidance is essential for pediatric and family medicine practices where parents may be cannabis users, requiring proactive harm reduction counseling at well-child visits and during discussions of household safety. Clear, evidence-based storage recommendations give clinicians concrete prevention strategies to reduce pediatric cannabis exposures, which have increased significantly in states with legalization.
This public health advisory emphasizes the serious poisoning risks that cannabis products pose to young children, who may accidentally ingest edibles, oils, or other formulations that are often indistinguishable from conventional candies or foods. Unintentional pediatric cannabis ingestion can result in significant toxicity, including altered mental status, respiratory depression, seizures, and in severe cases, death. The Missouri Department of Health recommends that all cannabis products be stored in locked containers or secured cabinets similar to other potentially toxic household medications, with particular attention to keeping products away from children’s reach and sight. This guidance reflects the reality that many households now contain cannabis in various forms, creating new poison control risks that pediatricians and emergency physicians should be aware of when evaluating young children with unexplained neurological or behavioral changes. Clinicians should routinely screen for household cannabis exposure during pediatric visits and counsel parents on safe storage practices as part of anticipatory guidance. The practical takeaway is that clinicians should treat cannabis products with the same safety precautions as prescription medications during parent education and should consider cannabis toxicity in the differential diagnosis of altered mental status in young children.
“This is straightforward harm reduction guidance that aligns with what we know about accidental pediatric exposures – THC products are potent, dosing in children is unpredictable, and we’ve documented serious outcomes from unintentional ingestion, so secure storage isn’t controversial medicine, it’s basic safety practice.”
🔒 Pediatric cannabis poisoning represents an often-underrecognized hazard in households with medical or recreational marijuana products, particularly given the appeal of edibles to young children and the delayed onset of symptoms that can complicate early recognition. While cannabis toxicity in children is rarely fatal, ingestion can cause significant morbidity including altered mental status, seizures, respiratory depression, and hypotension, with effects potentially more severe in very young children due to their lower body weight and developing physiology. Healthcare providers should routinely counsel parents and caregivers in their practices about secure storage of all cannabis products, employing the same harm-reduction language used for other household toxins and medications. It is important to acknowledge that counseling effectiveness depends partly on community norms around cannabis use and may require culturally sensitive approaches; additionally, not all patients will disclose cannabis in the home during standard history-taking. Incorporating a specific question about cannabis storage during well
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
